Ameritas Investment Partners’s Prime Medicine PRME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.3K Buy
8,407
+2,506
+42% +$9.54K ﹤0.01% 2409
2025
Q4
$20.5K Hold
5,901
﹤0.01% 2630
2025
Q3
$32.7K Buy
5,901
+2,000
+51% +$8.13K ﹤0.01% 2439
2025
Q2
$9.63K Hold
3,901
﹤0.01% 2992
2025
Q1
$7.76K Hold
3,901
﹤0.01% 2890
2024
Q4
$11.4K Hold
3,901
﹤0.01% 2868
2024
Q3
$15.1K Hold
3,901
﹤0.01% 2775
2024
Q2
$20.1K Hold
3,901
﹤0.01% 2612
2024
Q1
$27.3K Hold
3,901
﹤0.01% 2440
2023
Q4
$34.6K Hold
3,901
﹤0.01% 2344
2023
Q3
$37.2K Buy
3,901
+634
+19% +$8.23K ﹤0.01% 2254
2023
Q2
$47.9K Buy
3,267
+2,436
+293% +$34K ﹤0.01% 2080
2023
Q1
$10.2K Hold
831
﹤0.01% 2719
2022
Q4
$13.9K Buy
+831
New +$15K ﹤0.01% 2701

Other funds holding PRME